An important chemical used in an anti viral drug against Covid-19 is being produced in Eddyville, Iowa

Published: Apr. 14, 2021 at 10:05 PM CDT
Email This Link
Share on Pinterest
Share on LinkedIn

EDDYVILLE, Iowa (KYOU) - Remdesivir is the anti-viral drug owned by the Gilead Sciences Company, was the first drug approved by the FDA for emergency use in treating Covid-19 patients in May 2020.

The Wacker facility Site Director, Gregory Call, says his facility provides the chemical necessary to create the drug.

“We contribute to that supply chain with beta-cyclodextrin, what we call Cavamax W7, that we produce here in Eddyville.”

Wacker is the only facility in the world to produce all three chemical types on a commercial scale.

He says Remdesivir is an antiviral treatment, not a vaccine, and is strictly used for those who are hospitalized.

“One of the things with Remdesivir is that it’s intravenously administered in a hospital setting only so it’s only given to hospitalized patients at this time.”

According to an article from the National Center for Biotechnology Information, the drug was trialed and proven effective against the Ebola virus in 2015.

Call says he believes that’s what sparked the idea for it to be used for covid.

“It was noticed that it appeared to be effective with coronaviruses, I think that’s where it got some traction early on within the start of this pandemic.”

He wanted to highlight the Eddyville team by saying despite the pandemic being a challenging year for all of his staff everyone showed great perseverance and executions for all duties asked of them.

Copyright 2021 KYOU. All rights reserved.